![New Patient Guidelines Released for Breast Cancer Screening and Diagnosis](https://www.g2intelligence.com/wp-content/uploads/2022/08/Aug31-2022.News_.BreastCancerScreeningPatientGuidelines-iStock-1800x1250-1-1080x675.jpg)
New Patient Guidelines Released for Breast Cancer Screening and Diagnosis
The new guidelines offer patients advice on when they should start their screening, and how often they should have it done.
The new guidelines offer patients advice on when they should start their screening, and how often they should have it done.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.
For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.
A recent study shows that the disease was detected sooner in high-risk individuals who underwent screening than those who did not.
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.